skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:062287/0670   Pages: 6
Recorded: 01/05/2023
Attorney Dkt #:GLOR_000
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 23
1
Patent #:
Issue Dt:
07/15/2003
Application #:
09347613
Filing Dt:
07/02/1999
Title:
NOVEL NEUROTROPHIC FACTORS
2
Patent #:
Issue Dt:
05/11/2004
Application #:
09662183
Filing Dt:
09/15/2000
Title:
NOVEL NEUROTROPHIC FACTORS
3
Patent #:
Issue Dt:
10/28/2008
Application #:
10356264
Filing Dt:
01/31/2003
Publication #:
Pub Dt:
06/30/2005
Title:
POLYMER CONJUGATES OF MUTATED NEUBLASTIN
4
Patent #:
Issue Dt:
10/02/2007
Application #:
10661984
Filing Dt:
09/12/2003
Publication #:
Pub Dt:
07/22/2004
Title:
NOVEL NEUROTROPHIC FACTORS
5
Patent #:
Issue Dt:
05/13/2014
Application #:
11573771
Filing Dt:
12/14/2007
Publication #:
Pub Dt:
10/09/2008
Title:
REFOLDING TRANSFORMING GROWTH FACTOR BETA FAMILY PROTEINS
6
Patent #:
Issue Dt:
09/11/2012
Application #:
11573773
Filing Dt:
07/24/2007
Publication #:
Pub Dt:
02/14/2008
Title:
NEUBLASTIN VARIANTS
7
Patent #:
Issue Dt:
04/15/2008
Application #:
11614599
Filing Dt:
12/21/2006
Publication #:
Pub Dt:
05/03/2007
Title:
METHODS OF TREATING PAIN USING NEUROTROPHIC FACTORS
8
Patent #:
Issue Dt:
02/02/2010
Application #:
12029917
Filing Dt:
02/12/2008
Publication #:
Pub Dt:
09/25/2008
Title:
METHODS OF ACTIVATING RET RECEPTOR TYROSINE KINASE USING NEUROTROPHIC FACTORS
9
Patent #:
Issue Dt:
06/25/2019
Application #:
12280772
Filing Dt:
02/27/2009
Publication #:
Pub Dt:
09/03/2009
Title:
TREATMENTS FOR NEUROLOGICAL DISORDERS
10
Patent #:
Issue Dt:
07/10/2012
Application #:
12632517
Filing Dt:
12/07/2009
Publication #:
Pub Dt:
11/18/2010
Title:
NEUROTROPHIC FACTORS AND METHODS OF USE THEREOF
11
Patent #:
NONE
Issue Dt:
Application #:
12672213
Filing Dt:
01/13/2011
Publication #:
Pub Dt:
06/09/2011
Title:
ANTI-NEUBLASTIN ANTIBODIES AND USES THEREOF
12
Patent #:
Issue Dt:
06/03/2014
Application #:
13145669
Filing Dt:
10/17/2011
Publication #:
Pub Dt:
02/02/2012
Title:
CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY
13
Patent #:
Issue Dt:
09/22/2015
Application #:
13679529
Filing Dt:
11/16/2012
Publication #:
Pub Dt:
09/12/2013
Title:
COMPOSITIONS AND METHODS FOR INCREASING VASCULARIZATION
14
Patent #:
Issue Dt:
06/06/2017
Application #:
13876088
Filing Dt:
06/17/2013
Publication #:
Pub Dt:
10/03/2013
Title:
IMPLANTABLE CELL DEVICE WITH SUPPORTIVE AND RADIAL DIFFUSIVE SCAFFOLDING
15
Patent #:
NONE
Issue Dt:
Application #:
14289956
Filing Dt:
05/29/2014
Publication #:
Pub Dt:
09/18/2014
Title:
Stimulation System and Method for Voice Lift
16
Patent #:
Issue Dt:
02/06/2018
Application #:
14821498
Filing Dt:
08/07/2015
Publication #:
Pub Dt:
11/26/2015
Title:
CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY
17
Patent #:
Issue Dt:
11/17/2020
Application #:
15582761
Filing Dt:
04/30/2017
Publication #:
Pub Dt:
08/17/2017
Title:
Implantable Cell Device with Supportive and Radial Diffusive Scaffolding
18
Patent #:
Issue Dt:
01/12/2021
Application #:
15851741
Filing Dt:
12/22/2017
Publication #:
Pub Dt:
06/28/2018
Title:
CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY
19
Patent #:
NONE
Issue Dt:
Application #:
17099356
Filing Dt:
11/16/2020
Publication #:
Pub Dt:
03/11/2021
Title:
IMPLANTABLE CELL DEVICE WITH SUPPORTIVE AND RADIAL DIFFUSIVE SCAFFOLDING
20
Patent #:
NONE
Issue Dt:
Application #:
17145877
Filing Dt:
01/11/2021
Publication #:
Pub Dt:
05/06/2021
Title:
CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY
21
Patent #:
NONE
Issue Dt:
Application #:
17417067
Filing Dt:
Publication #:
Pub Dt:
02/17/2022
Title:
Mammalian Cell Culture-Produced Neublastin Antibodies
22
Patent #:
NONE
Issue Dt:
Application #:
17676085
Filing Dt:
02/18/2022
Publication #:
Pub Dt:
01/05/2023
Title:
Therapeutic Protein Formulations
23
Patent #:
NONE
Issue Dt:
Application #:
17789653
Filing Dt:
06/28/2022
Publication #:
Pub Dt:
02/16/2023
Title:
Mammalian Cells Secreting GDNF and Their Therapeutic Use
Assignor
1
Exec Dt:
11/21/2022
Assignee
1
HALSOVAGEN 7
HUDDINGE, SWEDEN 14157
Correspondence name and address
ALAN F. FEENEY, ESQ.
FEENEY IP LAW, 235 PROMENADE STREET, SUITE 485
PROVIDENCE, RI 02908

Search Results as of: 05/02/2024 11:11 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT